Gene · 2266
Papers2,467
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,467
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic Characterization of Congenital Fibrinogen Disorders: A Retrospective Analysis of 102 Unrelated Patients in China. | Semin Thromb Hemost | 2026 | 41297894 | PubTator, text mining | PubMed |
| Congenital hypofibrinogenemia with bleeding risk: mutations in the FGA, FGB, and FGG genes. | Lab Med | 2026 | 41233956 | PubTator, text mining | PubMed |
| Altered hemostatic dynamics and its regulation in follicular microenvironment of women with polycystic ovary syndrome. | Biochimie | 2026 | 41022169 | PubTator, text mining | PubMed |
| Data-independent acquisition-mass spectrometry proteomic analysis reveals fibrinogen α, β, and γ chains as candidate biomarkers for the nonmaturation of autogenous arteriovenous fistula. | Int Urol Nephrol | 2026 | 40999258 | PubTator, text mining | PubMed |
| Post-functionalized ZIF-8 for high-performance synergistic isolation of extracellular vesicles via co-precipitation. | Talanta | 2026 | 40986934 | PubTator, text mining | PubMed |
| Identification of Molecular Subtypes and a Novel Prognostic Model for Lung Squamous Cell Carcinoma Based on Adenylate Uridylate (AU)-Rich Element Genes. | J Immunother | 2026 | 40984041 | PubTator, text mining | PubMed |
| Genetic mutations associated with congenital fibrinogen disorders: global distribution and clinical outcomes. | J Thromb Thrombolysis | 2026 | 40879865 | PubTator, text mining | PubMed |
| A Mn-O-Ce interface-engineered nanozyme platform for visual stratified exosome screening of lung cancer: Toward primary care application. | Talanta | 2026 | 40850274 | PubTator, text mining | PubMed |
| Prevalence of haemostatic genes' polymorphisms in men and women with venous thromboembolism in the Czech Republic - a population-based study of cases and controls. | Cas Lek Cesk | 2025 | 41582910 | PubTator, text mining | PubMed |
| Modelling severe COVID-19 in TLR3-mutated hiPSCs-derived lung organoids. | Cell Death Discov | 2025 | 41453867 | PubTator, text mining | PubMed |
| Development of a MassARRAY Genotyping Platform and Its Clinical Application for Venous Thromboembolism Risk Assessment in Thai Patients. | Med Sci (Basel) | 2025 | 41440514 | PubTator, text mining | PubMed |
| Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis. | Nat Commun | 2025 | 41315260 | PubTator, text mining | PubMed |
| Fibrinogen alpha and beta chains as non-invasive predictors of hepatocellular carcinoma progression. | Sci Rep | 2025 | 41309856 | PubTator, text mining | PubMed |
| Beyond the Genotype: A Multi-Omic Analysis of APOEe4's Role in Alzheimer's Disease. | bioRxiv | 2025 | 41279801 | PubTator, text mining | PubMed |
| Fibrinogen Gamma Chain Mediates Airway Inflammation and Remodeling Through the Focal Adhesion and TGF-β/Smad2 Pathways in Chronic Obstructive Pulmonary Disease. | Lung | 2025 | 41254304 | PubTator, text mining | PubMed |
| Integrative bioinformatics and experimental validation unveil CRISP3 as a hypoxia-, epithelial mesenchymal transition-, and immune-related prognostic biomarker and therapeutic target in breast cancer. | Front Immunol | 2025 | 41200166 | PubTator, text mining | PubMed |
| The Urinary Proteome Differs with the Presence and Type of Breast Cancer. | J Proteome Res | 2025 | 41181894 | PubTator, text mining | PubMed |
| Bioinformatics analysis of the proteome in the pathway of complement and coagulation cascades in COVID-19: discovering potential biomarkers of FGB and SERPINA5. | BMC Infect Dis | 2025 | 41062954 | PubTator, text mining | PubMed |
| Implications of the c.1201C > G (p.Arg401Gly) mutation in FGG gene on fibrinogen stability and function. | Front Med (Lausanne) | 2025 | 41030265 | PubTator, text mining | PubMed |
| Exosomal FGG promotes colorectal cancer liver metastases through inducing angiogenic pre-metastatic niche formation. | Arch Biochem Biophys | 2025 | 41015146 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2266/papers?page=3